Neurotoxicologic concerns with vigabatrin.
Lhoir
A
A
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000614:Aminocaproates / Q000009:adverse effects*; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects*; D006801:Humans; D020888:Vigabatrin
D000614:Aminocaproates; D000927:Anticonvulsants; D000612:4-Aminobutyrate Transaminase; D020888:Vigabatrin